The Discovery of Novel Chemotypes of p38 Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-09 ,pp. : 953-965

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Flavone Propargyl Ethers as Potent and Selective Inhibitors of Cytochrome P450 Enzymes 1A1 and 1A2

By  

Drug Metabolism Letters, Vol. 6, Iss. 4, 2012-12 ,pp. : 275-284

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of HIV-1 Integrase Inhibitors through a Novel Combination of Ligand and Structure-based Drug Design

By  

Medicinal Chemistry, Vol. 1, Iss. 3, 2005-05 ,pp. : 263-275

Bentham Science Publishers

Access to resources Recommend Favorite

Protease inhibitors - Part 3. Synthesis of non-basic thrombin inhibitors incorporating pyridinium-sulfanilylguanidine moieties at the P1 site

By Scozzafava A.   Briganti F.   Supuran C.T.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 11, 1999-11 ,pp. : 939-952

Elsevier

Access to resources Recommend Favorite

P1 and P1; Optimization of [3,4]-Bicycloproline P2 Incorporated Tetrapeptidyl -Ketoamide Based HCV Protease Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 2, 2005-03 ,pp. : 118-123

Bentham Science Publishers

Access to resources Recommend Favorite